Data / Form D filings / Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc.: Form D filings
Ra Pharmaceuticals, Inc., a pharmaceuticals company in Cambridge, MA, filed 2 Form D notices with the SEC between 2010 and 2015. The latest, on July 23, 2015, reports $29.2 million sold of a $58.5 million offering to 11 investors.
Find out what Ra Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE KENDALL SQUARE, SUITE B14301, Cambridge, MA, 02139
- Phone
- (617) 401-4060
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1481512
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 23, 2015 | New notice | $58,499,990 | $29,249,996 | $29,249,994 | 11 | Jul 10, 2015 | sec.gov |
| Feb 24, 2010 | New notice | $27,613,067 | $10,333,082 | $17,279,985 | 5 | Feb 12, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas A. Treco | Executive Officer, Director | |
| Edward A. Mathers | Director | |
| Rajeev A. Shah | Director | |
| Peter A. Bisgaard | Director | |
| Jason A. Lettman | Director | |
| Kerry A. Black | Executive Officer | |
| Markus A. Goebel | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jul 20, 2015 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Ra Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.